<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>50610272646346</udiDi>
    <basicUdiDi>B-50610272646346</basicUdiDi>
    <tradeName>Anti-A Monoclonal</tradeName>
    <deviceName>Anti-A Monoclonal</deviceName>
    <manufacturerName>Rapid Labs Ltd</manufacturerName>
    <manufacturerSrn>GB-MF-000026335</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BG-A10</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:33:47.819Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682484709796</udiDi>
    <basicUdiDi>B-08682484709796</basicUdiDi>
    <tradeName>Cell Reverse A1B</tradeName>
    <deviceName>Cell Reverse A1B</deviceName>
    <manufacturerName>RED CELL BİYOTEKNOLOJİ A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000026921</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RCRBC2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-08T18:12:41.953Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682484709239</udiDi>
    <basicUdiDi>B-08682484709239</basicUdiDi>
    <tradeName>Cell Reverse A1B</tradeName>
    <deviceName>Cell Reverse A1B</deviceName>
    <manufacturerName>RED CELL BİYOTEKNOLOJİ A.Ş.</manufacturerName>
    <manufacturerSrn>TR-MF-000026921</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RCRBC2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-08T18:12:02.665Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-05060599400143GU</udiDi>
    <basicUdiDi>B-05060599400143GU</basicUdiDi>
    <tradeName>Anti-B Monoclonal</tradeName>
    <deviceName>Anti-B Monoclonal</deviceName>
    <manufacturerName>Rapid Labs Ltd</manufacturerName>
    <manufacturerSrn>GB-MF-000026335</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BG-B10</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-06T05:24:39.219Z</lastUpdated>
  </row>
  <row>
    <udiDi>03770008181694</udiDi>
    <basicUdiDi>B-03770008181694</basicUdiDi>
    <tradeName>03770008181694</tradeName>
    <deviceName>Hématies tests à 2,5% pour épreuve plasmatique</deviceName>
    <manufacturerName>Institut de Biotechnologies Jacques Boy</manufacturerName>
    <manufacturerSrn>FR-MF-000004609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>157240163</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T19:21:52.820Z</lastUpdated>
  </row>
  <row>
    <udiDi>03770008181588</udiDi>
    <basicUdiDi>B-03770008181588</basicUdiDi>
    <tradeName>03770008181588</tradeName>
    <deviceName>Anti-B monoclonal (clone B2A22)</deviceName>
    <manufacturerName>Institut de Biotechnologies Jacques Boy</manufacturerName>
    <manufacturerSrn>FR-MF-000004609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>152210263</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T19:21:46.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>03770008181595</udiDi>
    <basicUdiDi>B-03770008181595</basicUdiDi>
    <tradeName>03770008181595</tradeName>
    <deviceName>Anti-A monoclonal (clone 26A2)</deviceName>
    <manufacturerName>Institut de Biotechnologies Jacques Boy</manufacturerName>
    <manufacturerSrn>FR-MF-000004609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>152210163</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T19:21:44.129Z</lastUpdated>
  </row>
  <row>
    <udiDi>03770008181571</udiDi>
    <basicUdiDi>B-03770008181571</basicUdiDi>
    <tradeName>03770008181571</tradeName>
    <deviceName>Anti-AB monoclonal (clones 152D12+9113D10)</deviceName>
    <manufacturerName>Institut de Biotechnologies Jacques Boy</manufacturerName>
    <manufacturerSrn>FR-MF-000004609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste A</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0103030101</emdnCode>
    <emdnDescription>ABO GROUPING CELLS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>152210363</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T19:21:30.359Z</lastUpdated>
  </row>
</eudamedExport>